Ile-His-OCH3 | 114662-56-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Ile-His-OCH3
• 英文别名: methyl (2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoate
• CAS: 114662-56-5
• 化学式: C₁₃H₂₂N₄O₃
• 分子量: 282.343
• InChiKey: HKUHZKQDYVVBMP-LSJOCFKGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  20
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  110
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  Ile-His-OCH3 在 N-甲基吗啉 、 盐酸 、 1-羟基苯并三唑 、 N,N'-二环己基碳二亚胺 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.5h， 生成 AHMOA-Ile-His-OMe hydrochloride
  参考文献：
  名称：

  Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid

  摘要：

  The 3R,5S and 3S,5S diastereoisomers of the hydroxy amino acid 5-amino-3-hydroxy-7-methyloctanoic acid (AHMOA) were synthesized from L-leucine and then incorporated into various peptide fragments of angiotensinogen to give the following polypeptides: AHMOA-Val-Phe-OCH3, His-AHMOA-Val-Phe-OCH3, and AHMOA-Ile-His-OCH3. These compounds were tested in an in vitro renin assay system for their ability to inhibit either hog kidney renin or human amniotic renin. The most active analogue of the series was (3R,5S)-AHMOA-Val-Phe-OCH3 (16). Against hog kidney renin, this compound possessed a Ki = 1.7 X 10(-4) M, while against human amniotic fluid, 16 had a Ki = 0.95 X 10(-4) M. The analogues AHMOA-Val-Phe-OCH3 and His-AHMOA-Val-Phe-OCH3 exhibited noncompetitive kinetics when the 3R,5S isomer of AHMOA was employed and competitive kinetics when the 3S,5S diastereoisomer of AHMOA was used.

  DOI：

  10.1021/jm00364a019

文献信息

• Amino acid derivatives
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP0386611A2

  公开（公告）日：1990-09-12

  Compounds of the formula wherein R¹ represents alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, aralkanoyl, aroyl, cycloalkylcarbonyl, heterocyclylcarbonyl, heterocyclyl-alkanoyl, 6-(dibenzylcarbamoyl)-4-oxohexanoyl or an acyl group of an α-amino acid in which the amino group is substituted by alkoxycaronyl, aralkoxycarbonyl, diaralkylcarbamoyl, diaralkylalkanoyl or aralkanoyl; R² represents alkyl, cycloalkylalkyl or aralkyl; R³ represents hydrogen or alkyl; R⁴ represents alkyl; and one of R⁵ and R⁶ represents hydrogen and the other represents hydrogen, alkyl, aryl, aralkyl, 1-alkoxycarbonyl-2-phenylethyl, 1-alkoxycarbonyl-2-(imidazol-4-yl)ethyl, 2-(imidazol-1-yl)ethyl, indanyl, heterocyclyl-alkyl, carboxyalkyl, alkoxycarbonylalkyl, aryloxycarbonylalkyl, aralkoxycarbonylalkyl or a group of the formula -A-N(Ra)(Rb) in which A represents alkylene and Ra and Rb each represent alkyl or Ra and Rb together represent a pentamethylene group in which one methylene group can be replaced by NH, N-alkyl, N-alkanoyl, N-aralkoxy carbonyl, O, S, SO or SO₂; or R⁵ and R⁶ together with the nitrogen atom to which they are attached represent a 1,2,3,4-tetrahydroisoquinoline ring; one of W and X represents hydrogen and the other represents hydroxy or amino or W and X together represent hydroxyimino and Y represents hydrogen or, where one of W and X represents hydrogen and the other represents hydroxy, Y can also represent hydroxy, and pharmaceutically acceptable acid addition salts thereof can be used as medicaments for the treatment and prophylaxis of viral infections, particularly of infections caused by HIV and other retroid viruses. They can be manufactured according to generally known procedures.

  式中的化合物 其中 R¹ 代表烷氧基羰基、烷氧基羰基、烷酰基、烷酰基、芳酰基、环烷基羰基、杂环烷基羰基、杂环烷酰基、6-(二苄基氨基甲酰基)-4-氧代己酰基或 α-氨基酸的酰基，其中氨基被烷氧基羰基、烷氧基羰基、二烷基氨基甲酰基、二烷基烷酰基或芳酰基取代；R² 代表烷基、环烷基烷基或芳烷基； R³ 代表氢或烷基； R⁴ 代表烷基；R⁵ 和 R⁶ 中的一个代表氢，另一个代表氢、烷基、芳基、芳烷基、1-烷氧基羰基-2-苯基乙基、1-烷氧基羰基-2-(咪唑-4-基)乙基、2-(咪唑-1-基)乙基、茚基、杂环烷基、羧基、烷氧基羰基烷基、芳氧基羰基烷基、烷氧基羰基烷基、芳氧基羰基烷基、芳氧基羰基烷基、芳氧基羰基烷基、芳氧基羰基烷基、芳氧基羰基烷基或 R⁵ 和 R⁶ 与它们所连接的氮原子一起代表 1，2，3，4-四氢异喹啉环； W 和 X 中的一个代表氢，另一个代表羟基或氨基，或 W 和 X 一起代表羟基亚氨基，Y 代表氢，或 W 和 X 中的一个代表氢，另一个代表羟基，Y 也可以代表羟基、 及其药学上可接受的酸加成盐可用作治疗和预防病毒感染的药物，特别是由 HIV 和其他逆转录病毒引起的感染。它们可以按照一般已知的程序制造。
• Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid
  作者：Rodney L. Johnson、Karen Verschoor

  DOI：10.1021/jm00364a019

  日期：1983.10

  The 3R,5S and 3S,5S diastereoisomers of the hydroxy amino acid 5-amino-3-hydroxy-7-methyloctanoic acid (AHMOA) were synthesized from L-leucine and then incorporated into various peptide fragments of angiotensinogen to give the following polypeptides: AHMOA-Val-Phe-OCH3, His-AHMOA-Val-Phe-OCH3, and AHMOA-Ile-His-OCH3. These compounds were tested in an in vitro renin assay system for their ability to inhibit either hog kidney renin or human amniotic renin. The most active analogue of the series was (3R,5S)-AHMOA-Val-Phe-OCH3 (16). Against hog kidney renin, this compound possessed a Ki = 1.7 X 10(-4) M, while against human amniotic fluid, 16 had a Ki = 0.95 X 10(-4) M. The analogues AHMOA-Val-Phe-OCH3 and His-AHMOA-Val-Phe-OCH3 exhibited noncompetitive kinetics when the 3R,5S isomer of AHMOA was employed and competitive kinetics when the 3S,5S diastereoisomer of AHMOA was used.